These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8623182)

  • 1. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene KA
    Transplantation; 1996 Apr; 61(7):1038-46. PubMed ID: 8623182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised, prospective study on the conversion from cyclosporine-prednisone to cyclosporine-azathioprine at 6 months after renal transplantation.
    de Sévaux RG; Hilbrands LB; Tiggeler RG; Koene RA; Hoitsma AJ
    Transpl Int; 1998; 11 Suppl 1():S322-4. PubMed ID: 9665006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of immunosuppressive drugs on quality of life after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene RA
    Transplantation; 1995 May; 59(9):1263-70. PubMed ID: 7762059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
    Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
    MacPhee IA; Bradley JA; Briggs JD; Junor BJ; MacPherson SG; McMillan MA; Rodger RS; Watson MA
    Transplantation; 1998 Nov; 66(9):1186-92. PubMed ID: 9825816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.
    Smak Gregoor PJ; de Sévaux RG; Ligtenberg G; Hoitsma AJ; Hené RJ; Weimar W; Hilbrands LB; van Gelder T
    J Am Soc Nephrol; 2002 May; 13(5):1365-73. PubMed ID: 11961025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
    Hilbrands LB; Demacker PN; Hoitsma AJ; Stalenhoef AF; Koene RA
    J Am Soc Nephrol; 1995 Jun; 5(12):2073-81. PubMed ID: 7579056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complications in geriatric renal transplant patients: comparison of two immunosuppressive protocols.
    Meier-Kriesche HU; Friedman G; Jacobs M; Mulgaonkar S; Vaghela M; Kaplan B
    Transplantation; 1999 Nov; 68(10):1496-502. PubMed ID: 10589946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
    Wüthrich RP; Weinreich T; Ambühl PM; Schwarzkopf AK; Candinas D; Binswanger U
    Nephrol Dial Transplant; 1999 Feb; 14(2):394-9. PubMed ID: 10069195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
    Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J
    Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
    Schulak JA; Mayes JT; Moritz CE; Hricik DE
    Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
    Song Y; Xue W; Tian P; Ding X; Pan X; Yan H; Hou J; Feng X; Xiang H; Tian X; Qin G; Fan X
    Eur J Clin Pharmacol; 2011 Jun; 67(6):553-62. PubMed ID: 21279337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.